Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffb994e296b2fadb2b0eca2621a8d291 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2019-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e03252ea4f8769c803fa08965c89d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e287dea6b5ebb498ca0fbc44b95e128b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50908eae675cf4dc388f99ba07bc02d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a198161456bab83bf32bdd1076cb42cd |
publicationDate |
2021-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3849577-A1 |
titleOfInvention |
Short cyclic peptides for the treatment of graves' disease |
abstract |
The present invention relates to short cyclic peptides, their use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same. |
priorityDate |
2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |